Commercial Litigation UK

  • March 31, 2025

    Nokia, Amazon End Long-Running Patent Feud With License

    Nokia said Monday that it has inked a patent agreement with Amazon to cover its video technology, marking the end of litigation between the two companies across several continents.

  • March 28, 2025

    VistaJet Escapes VC Fund's Claim Over Investment Deal

    A private jet company owner escaped allegations from a Guernsey venture capital fund that he secretly set up companies to leverage the resources of a business it had invested in, when a London court ruled Friday that the claim came too late.

  • March 28, 2025

    UK Litigation Roundup: Here's What You Missed In London

    This past week in London has seen sparkling winemaker Nyetimber hit a rival distillery with an intellectual property claim, Newcastle United's former owner Mike Ashley target the club's ex-vice president for damages tied to a fraudulent investment, and a real estate agency file a legal claim against law firm Winston & Strawn LLP. Here, Law360 looks at these and other new claims in the U.K.

  • March 28, 2025

    Dale Vince Settles Libel Case Against Guido Fawkes Owner

    Green industrialist Dale Vince told a London court on Friday that he was ending his libel action against the owner of political blog Guido Fawkes, which published an article claiming that the businessman had said that Hamas were "freedom fighters."

  • March 28, 2025

    'We Didn't Have A Precedent': Lawyers Test New Regime

    As part of a series of interviews with lawyers, class representatives and litigation-funders to mark the 10-year anniversary of the collective proceedings order regime, Law360 spoke to Boris Bronfentrinker and Ricky Versteeg — lawyers on opposite sides of the courtroom — about the watershed Mastercard swipe fees case.

  • March 28, 2025

    Ex-BMW Staffer Can Revive Union Case After Legal Shift

    An appeals court ruled Friday that a former BMW staffer could revive claims that bosses punished and fired her over trade union activities, ruling that a new precedent now permitted late submissions of documents in an appeal request. 

  • March 28, 2025

    Santander Whistleblower Cannot Add FCA Info To Claim

    An employment tribunal has rejected a former financial crime policy manager's bid to widen her second whistleblowing claim against Santander to include correspondence with the financial watchdog, ruling that the changes were too fundamental to the basis of her claim.

  • March 28, 2025

    Southern Electricity Co. Wins £2.6M Cable Replacement Spat

    An English power company has won its £2.6 million ($3.3 million) claim against a power design contractor after a London judge ruled that it was "objectively reasonable" to assume that defects in underground cable circuits caused by a contractor's defective work were "widespread."

  • March 28, 2025

    Engineering Firm Beats Staffer's Long COVID Bias Claim

    Engineering giant Amey did not discriminate against a bid writer who had long COVID-19 by offering him a lower pay rise than most of his colleagues, a tribunal held in a decision published Friday.

  • March 28, 2025

    Pharma Co. Sues Ex-VP For Trade Theft To Benefit Rival

    A pharma company has sued its former senior vice president, accusing him of secretly downloading confidential information in order to share it with a rival weeks before he resigned. 

  • March 28, 2025

    Wealth Manager Beats €50M Investment Fraud Case

    A wealth manager has defeated a €50 million ($54.1 million) investment fraud case brought by an Italian investment vehicle, after a London judge ruled Friday that the losses were the result of "market turmoil" caused by the COVID-19 pandemic.

  • March 28, 2025

    MSD Loses Appeal Over Ruling It Broke 'Merck' Branding Ban

    A London appeals court upheld on Friday a ruling that U.S.-based Merck Sharp & Dohme LLC breached a court order blocking its use of the name "Merck" in a move to safeguard German rival Merck KGaA's trademark rights.

  • March 28, 2025

    TUI Denies Liability For Holidaymakers' Illness In Mexico

    TUI has hit back against a claim from 23 holidaymakers who say they were struck with gastroenteritis during a stay at a resort in Mexico, saying the customers must prove the illness was caused by food consumed during the all-inclusive vacation package.

  • March 28, 2025

    AstraZeneca Sues Consultancy For £32M Over HQ Defects

    AstraZeneca UK Ltd. has sued a fire engineering consultancy for £31.7 million ($41.1 million) over allegedly "widespread" fire protection defects uncovered at the biotechnology company's £1 billion headquarters in Cambridge.

  • March 28, 2025

    Tesco Can't Add New Alleged 'Errors' To Equal Pay Appeal

    An attempt by retail giant Tesco to add a broad challenge to alleged factual errors in a claim for equal pay brought by more than 50,000 female shop floor workers was tossed by an appeals tribunal on Friday.

  • March 28, 2025

    AstraZeneca Can't Stop Generic Diabetes Drug Launch

    AstraZeneca has lost an attempt to prevent pharmaceutical company Glenmark from launching a generic version of its $1 billion diabetes drug Forxiga, as a London court refused on Friday to stop the generic maker before a decision on whether AstraZeneca's patent is valid.

  • March 27, 2025

    Oligarch's Ex-Wife Ends Payne Hicks Negligence Case

    A Russian oligarch's former wife has ended a negligence action against Payne Hicks Beach LLP over claims it failed to exercise the proper care and skill in a divorce battle involving the oligarch's £200 million ($260 million) yacht.

  • March 27, 2025

    Railway Questions Class Rep's Suitability In Fare Dispute

    Govia Thameslink Railway Ltd. asked the U.K.'s antitrust tribunal on Thursday to demand extra evidence from the campaigner seeking to represent rail passengers in a class action over allegedly unfair ticket prices, saying he must prove he is a suitable representative.

  • March 27, 2025

    AstraZeneca Fights Generic Diabetes Drug Launch

    AstraZeneca on Thursday asked a London court to block pharmaceutical company Glenmark from launching a generic version of the drug giant's $1 billion Type 2 diabetes treatment Forxiga, ahead of a decision on whether AstraZeneca's patent is valid.

  • March 27, 2025

    WhatsApp Should Get To Fight €225M GDPR Fine, ECJ Urged

    WhatsApp should be allowed to challenge a European Union board's order for Irish authorities to increase a data protection fine that topped out at €225 million ($243 million), an adviser to the bloc's top court said Thursday.

  • March 27, 2025

    'A Challenge We Have To Rise To': Class Reps Take The Stage

    Launching a series of interviews with lawyers, class representatives and litigation-funders to mark the 10-year anniversary of the collective proceedings order regime, Law360 spoke to Justin Gutmann and Rachael Kent about how the role of class reps has evolved in the decade since CPOs were introduced

  • March 27, 2025

    Key Moments That Formed The UK's Class Action Regime

    The U.K.'s collective proceedings regime — introduced a decade ago — has grown rapidly after a slow start. Law360 looks here at the biggest moments of the regime so far and what's ahead.

  • March 27, 2025

    Huawei Defeats Widow's Delayed Claim Over Unpaid OT

    A former Huawei employee's widow can't pursue the company for allegedly discriminating against her husband because she waited too long to launch her case, an employment tribunal has ruled.

  • March 27, 2025

    Former Barclays Exec Fights For £3.5M Deferred Bonus

    A former head of credit trading at Barclays has argued that he is owed a £3.5 million ($4.5 million) bonus package after he left the bank and joined a hedge fund following his son's diagnosis with a rare disease.

  • March 27, 2025

    Top EU Court Urged To Uphold €60M Teva Pay-For-Delay Fine

    An adviser to the European Union's top court said Thursday that it should uphold €60.5 million ($70.7 million) in fines against Teva and its subsidiary Cephalon for an alleged conspiracy to keep a generic version of Provigil off the shelves.

Expert Analysis

  • How Law Firms Can Handle Challenges Of Mass Claims

    Author Photo

    With a wave of volume litigation possibly about to hit the U.K. courts, firms developing mass claim practices should ensure they heed the Solicitors Regulation Authority's May warning and adopt strategies to ensure regulatory compliance and fair client representation, says Claire Van der Zant at Shieldpay.

  • Potential EPO Reproducibility Ruling May Affect IP Strategies

    Author Photo

    A potential European Patent Office decision in referral G1/23, concerning the reproducibility criteria for patenting commercial products, may affect how disclosures are assessed as prior art and could influence how companies weigh protecting innovations as trade secrets versus patents, says Michael Stott at Mathys & Squire.

  • Insurance Ruling Stresses High Hurdle To Fix Policy Wording

    Author Photo

    In Project Angel v. Axis, the Court of Appeal recently refused to rewrite the exclusion clause of an insurance policy, reminding parties in the warranty and indemnity market to carefully word clauses, as there is a high threshold before courts will intervene to amend policies, say Joseph Moore and Laura McCann at Travers Smith.

  • Taking Stock Of Changes UK Economic Crime Act Will Bring

    Author Photo

    With more than six months since the Economic Crime and Corporate Transparency Act's enactment, it is time to look at the steps organizations can take to prepare for imminent changes, including the new failure to prevent fraud offense and extensions to Companies House authority, say lawyers at Mayer Brown.

  • Sanctions Ruling Opens Door For Enforcer To Clear Up Rules

    Author Photo

    In Vneshprombank v. Bedzhamov, the High Court recently argued against a broader interpretation of the test on reasonable suspicion for asset freezes, offering the Office of Financial Sanctions Implementation an opportunity to clarify when freezes should be applied and respond to judicial criticism of its guidance on financial sanctions, says Tasha Benkhadra at Corker Binning.

  • How Gov't Response Addresses Investment Act Concerns

    Author Photo

    The government’s recently published response to a call for evidence on the National Security and Investment Act is largely appropriate to stakeholder concerns raised and demonstrates in its five areas of focus that it is willing to respond to live issues, say lawyers at Watson Farley.

  • UPC Appeal Ruling Clarifies Language Change Framework

    Author Photo

    In 10x Genomics v. Curio Bioscience, the Unified Patent Court recently allowed proceedings to be conducted in English, rather than German, shedding light on the framework on UPC language change applications and hopefully helping prevent future disputes, say Conor McLaughlin and Nina O'Sullivan at Mishcon de Reya.

  • How Generative AI Can Enhance Disclosure Review Processes

    Author Photo

    As recent developments show that implementing artificial intelligence in legal processes remains a critical challenge, the disclosure process — one of the most document-intensive legal exercises — presents itself as a prime use-case, illustrating how generative AI can supplement traditional technology-assisted review, say lawyers at Macfarlanes.

  • Decoding Arbitral Disputes: The Benefits Of Non-EU Venues

    Author Photo

    In Spain v. Triodos, a Swedish appeal court recently annulled an intra-EU investment treaty award, reinforcing a growing trend in the bloc against enforcing such awards, and highlighting the advantages of initiating enforcement proceedings in common law jurisdictions, such as the U.K., says Josep Galvez at 4-5 Gray's Inn Square.

  • Experian Ruling Helps Cos. Navigate GDPR Transparency

    Author Photo

    In Information Commissioner v. Experian, the Upper Tribunal recently reaffirmed the lawfulness of the company's marketing practices, providing guidance that will assist organizations in complying with the GDPR’s transparency obligations, say lawyers at Jenner & Block.

  • Salvaging The Investor-State Arbitration System's Legitimacy

    Author Photo

    Recent developments in Europe and Ecuador highlight the vulnerability of the investor-state arbitration framework, but arbitrators can avert a crisis by relying on a poorly understood doctrine of fairness and equity, rather than law, to resolve the disputes before them, says Phillip Euell at Diaz Reus.

  • UK Trademark Law May Further Diverge From EU Standards

    Author Photo

    The recently enacted Retained EU Law Act, which removes the principle of EU law supremacy, offers a path for U.K. trademark law to distance itself even further from EU precedent — beyond the existing differences between the two trademark examination processes, say David Kemp and Michael Shaw at Marks & Clerk.

  • Clarity Is Central Theme In FCA's Greenwashing Guidance

    Author Photo

    Recent Financial Conduct Authority guidance for complying with the U.K. regulator's anti-greenwashing rule sends an overarching message that sustainability claims must be clear, accurate and capable of being substantiated, say lawyers at Cadwalader.

  • How Clinical Trials Affect Patentability In US And Europe

    Author Photo

    A comparison of recent U.S. and European patent decisions — concerning the effect of disclosures in clinical trials on the patentability of products — offers guidance on good practice for companies dealing with public use issues and prior art documents in these commercially important jurisdictions, say lawyers at Finnegan.

  • ECHR Ruling May Pave Path For A UK Climate Damage Tort

    Author Photo

    In light of case law on the interaction between human rights law and common law, the European Court of Human Rights' recent ruling in KlimaSeniorinnen v. Switzerland, finding the country at fault for failures to tackle global warming, could tip the scales toward extending English tort law to cover climate change-related losses, say lawyers at Cleary.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Commercial Litigation UK archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!